世界の心不全治療薬市場は2023年に約239億8,000万米ドルと評価され、2024年から2032年の予測期間にわたって10.46%を超える健全な成長率で成長すると予想されています。
心不全治療薬は、心臓疾患にかかりやすい高齢化社会に刺激されて、上昇傾向にあります。医療技術の進歩により心不全の治療と管理が向上し、発展途上国では所得水準と健康意識の高まりにより医療費が増加しています。質の高いケアを求める人々の熱意に後押しされ、高度な治療に対する需要は高まり続けており、政府や民間企業は研究開発（R&D）への投資を増強しています。これらの成長要因の中には、大きなチャンスが潜んでいます。製薬業界とバイオテクノロジー業界は、最先端の医薬品や生物学的ソリューションを発表する準備ができており、患者のモニタリングや分析などのデジタルヘルスツールは、ケアの基準を再定義する準備ができています。バイオテクノロジーの新興企業のイノベーションと既存の製薬会社の影響力を組み合わせた戦略的提携が業界全体で形成され、パーソナライズされた医療への動きは、高度に個別化された治療への扉を開きます。
世界の心不全治療薬市場は、いくつかの重要な要因に後押しされ、堅調な成長を遂げています。慢性疾患の蔓延が拡大していることと、疾患の進行を研究し、標的治療薬を開発するためのより正確なモデルが切実に求められていることが相まって、高度な心不全治療薬の需要が高まっています。たとえば、大手メーカー、大学、非営利団体、連邦政府から、さまざまな研究所に 3,000 億ドルを超える多額の投資が行われています。この資金援助は、人工組織や臓器のスケーラブルな製造プロセスの開発を促進することを目的としており、心不全治療技術の進歩に対する業界の取り組みを反映しています。しかし、この市場は規制の複雑さと償還の課題に直面しています。研究開発と治療ソリューションに関連する高額なコストは、市場の成長を妨げる可能性があります。さらに、一部の地域で心不全の診断不足や無知、ジェネリック医薬品の競争につながる主要医薬品の特許の失効、治療と生活習慣に対する患者の遵守に関する継続的な問題などが障害となっています。
世界の心不全治療薬市場調査で検討される主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域が含まれます。2023年には、北アメリカが市場で最大の地域市場となりました。この地域の市場成長は、Abbott Laboratories社やJohnson & Johnson社の主要企業の存在と、心不全治療薬の製造技術の進歩によって推進されています。さらに、この地域は医療インフラが整備されており、研究開発（R＆D）に多額の投資が行われているため、心不全治療薬などの最先端技術の進歩と採用につながる環境が整っています。これらの要因が相まって市場の成長を牽引し、この地域は心不全治療薬の分野における革新と開発の拠点となっています。一方、アジア太平洋地域の市場は、心不全治療の需要の大きな変化により、予測期間中に最も速いペースで成長すると予想されています。
目次
Table of Contents
Chapter 1. Global Heart Failure Therapeutics Market Executive Summary
1.1. Global Heart Failure Therapeutics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Treatment
1.3.2. By Type
1.3.3. By Stage
1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Heart Failure Therapeutics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Heart Failure Therapeutics Market Dynamics
3.1. Market Drivers
3.1.1. Aging population and rising prevalence of heart failure
3.1.2. Advancements in medical technology and treatment options
3.1.3. Increased healthcare expenditure in developing economies
3.2. Market Challenges
3.2.1. Regulatory complexities and reimbursement issues
3.2.2. High R&D costs and therapeutic solution expenses
3.2.3. Underdiagnosis and unawareness in certain regions
3.3. Market Opportunities
3.3.1. Development of gene and stem cell therapies
3.3.2. Integration of AI and machine learning in diagnostics
3.3.3. Growth in remote patient monitoring and digital health tools
Chapter 4. Global Heart Failure Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Heart Failure Therapeutics Market Size & Forecasts by Treatment 2022-2032
5.1. Segment Dashboard
5.2. Global Heart Failure Therapeutics Market: Treatment Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Medical Devices
5.2.1.1. Bi-level positive air pressure device
5.2.1.2. Biventricular Pacemaker
5.2.1.3. Continuous Positive Air Pressure Device
5.2.1.4. Heart Pumps
5.2.1.5. Implantable Cardioverter-Defibrillators
5.2.1.6. Implantable Left Ventricular Assist Device
5.2.2. Medicines
5.2.2.1. Angiotensin II Receptor Blockers
5.2.2.2. Anticoagulant Medicines
5.2.2.3. Antiplatelet Medicines
5.2.2.4. Blood Pressure Maintaining Agents
5.2.2.5. Diuretics
5.2.2.6. Nitrates
5.2.2.7. Statins
5.2.3. Surgery
5.2.3.1. Cardiac Resynchronization
5.2.3.2. Coronary Artery Bypass Grafting
5.2.3.3. Coronary Revascularization
5.2.3.4. Heart Transplant
5.2.3.5. Heart Valve Replacement
Chapter 6. Global Heart Failure Therapeutics Market Size & Forecasts by Type 2022-2032
6.1. Segment Dashboard
6.2. Global Heart Failure Therapeutics Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Diagnosis
6.2.2. Prognosis
Chapter 7. Global Heart Failure Therapeutics Market Size & Forecasts by Stage 2022-2032
7.1. Segment Dashboard
7.2. Global Heart Failure Therapeutics Market: Stage Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Stage A
7.2.2. Stage B
7.2.3. Stage C
7.2.4. Stage D
Chapter 8. Global Heart Failure Therapeutics Market Size & Forecasts by End User 2022-2032
8.1. Segment Dashboard
8.2. Global Heart Failure Therapeutics Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Clinic
8.2.2. Hospital
8.2.3. Medical Research Organization
Chapter 9. Global Heart Failure Therapeutics Market Size & Forecasts by Region 2022-2032
9.1. North America Heart Failure Therapeutics Market
9.1.1. U.S. Heart Failure Therapeutics Market
9.1.1.1. Treatment breakdown size & forecasts, 2022-2032
9.1.1.2. Type breakdown size & forecasts, 2022-2032
9.1.1.3. Stage breakdown size & forecasts, 2022-2032
9.1.1.4. End User breakdown size & forecasts, 2022-2032
9.1.2. Canada Heart Failure Therapeutics Market
9.1.2.1. Treatment breakdown size & forecasts, 2022-2032
9.1.2.2. Type breakdown size & forecasts, 2022-2032
9.1.2.3. Stage breakdown size & forecasts, 2022-2032
9.1.2.4. End User breakdown size & forecasts, 2022-2032
9.2. Europe Heart Failure Therapeutics Market
9.2.1. U.K. Heart Failure Therapeutics Market
9.2.1.1. Treatment breakdown size & forecasts, 2022-2032
9.2.1.2. Type breakdown size & forecasts, 2022-2032
9.2.1.3. Stage breakdown size & forecasts, 2022-2032
9.2.1.4. End User breakdown size & forecasts, 2022-2032
9.2.2. Germany Heart Failure Therapeutics Market
9.2.2.1. Treatment breakdown size & forecasts, 2022-2032
9.2.2.2. Type breakdown size & forecasts, 2022-2032
9.2.2.3. Stage breakdown size & forecasts, 2022-2032
9.2.2.4. End User breakdown size & forecasts, 2022-2032
9.2.3. France Heart Failure Therapeutics Market
9.2.3.1. Treatment breakdown size & forecasts, 2022-2032
9.2.3.2. Type breakdown size & forecasts, 2022-2032
9.2.3.3. Stage breakdown size & forecasts, 2022-2032
9.2.3.4. End User breakdown size & forecasts, 2022-2032
9.2.4. Spain Heart Failure Therapeutics Market
9.2.4.1. Treatment breakdown size & forecasts, 2022-2032
9.2.4.2. Type breakdown size & forecasts, 2022-2032
9.2.4.3. Stage breakdown size & forecasts, 2022-2032
9.2.4.4. End User breakdown size & forecasts, 2022-2032
9.2.5. Italy Heart Failure Therapeutics Market
9.2.5.1. Treatment breakdown size & forecasts, 2022-2032
9.2.5.2. Type breakdown size & forecasts, 2022-2032
9.2.5.3. Stage breakdown size & forecasts, 2022-2032
9.2.5.4. End User breakdown size & forecasts, 2022-2032
9.2.6. Rest of Europe Heart Failure Therapeutics Market
9.2.6.1. Treatment breakdown size & forecasts, 2022-2032
9.2.6.2. Type breakdown size & forecasts, 2022-2032
9.2.6.3. Stage breakdown size & forecasts, 2022-2032
9.2.6.4. End User breakdown size & forecasts, 2022-2032
9.3. Asia-Pacific Heart Failure Therapeutics Market
9.3.1. China Heart Failure Therapeutics Market
9.3.1.1. Treatment breakdown size & forecasts, 2022-2032
9.3.1.2. Type breakdown size & forecasts, 2022-2032
9.3.1.3. Stage breakdown size & forecasts, 2022-2032
9.3.1.4. End User breakdown size & forecasts, 2022-2032
9.3.2. India Heart Failure Therapeutics Market
9.3.2.1. Treatment breakdown size & forecasts, 2022-2032
9.3.2.2. Type breakdown size & forecasts, 2022-2032
9.3.2.3. Stage breakdown size & forecasts, 2022-2032
9.3.2.4. End User breakdown size & forecasts, 2022-2032
9.3.3. Japan Heart Failure Therapeutics Market
9.3.3.1. Treatment breakdown size & forecasts, 2022-2032
9.3.3.2. Type breakdown size & forecasts, 2022-2032
9.3.3.3. Stage breakdown size & forecasts, 2022-2032
9.3.3.4. End User breakdown size & forecasts, 2022-2032
9.3.4. Australia Heart Failure Therapeutics Market
9.3.4.1. Treatment breakdown size & forecasts, 2022-2032
9.3.4.2. Type breakdown size & forecasts, 2022-2032
9.3.4.3. Stage breakdown size & forecasts, 2022-2032
9.3.4.4. End User breakdown size & forecasts, 2022-2032
9.3.5. South Korea Heart Failure Therapeutics Market
9.3.5.1. Treatment breakdown size & forecasts, 2022-2032
9.3.5.2. Type breakdown size & forecasts, 2022-2032
9.3.5.3. Stage breakdown size & forecasts, 2022-2032
9.3.5.4. End User breakdown size & forecasts, 2022-2032
9.3.6. Rest of Asia Pacific Heart Failure Therapeutics Market
9.3.6.1. Treatment breakdown size & forecasts, 2022-2032
9.3.6.2. Type breakdown size & forecasts, 2022-2032
9.3.6.3. Stage breakdown size & forecasts, 2022-2032
9.3.6.4. End User breakdown size & forecasts, 2022-2032
9.4. Latin America Heart Failure Therapeutics Market
9.4.1. Brazil Heart Failure Therapeutics Market
9.4.1.1. Treatment breakdown size & forecasts, 2022-2032
9.4.1.2. Type breakdown size & forecasts, 2022-2032
9.4.1.3. Stage breakdown size & forecasts, 2022-2032
9.4.1.4. End User breakdown size & forecasts, 2022-2032
9.4.2. Mexico Heart Failure Therapeutics Market
9.4.2.1. Treatment breakdown size & forecasts, 2022-2032
9.4.2.2. Type breakdown size & forecasts, 2022-2032
9.4.2.3. Stage breakdown size & forecasts, 2022-2032
9.4.2.4. End User breakdown size & forecasts, 2022-2032
9.4.3. Rest of Latin America Heart Failure Therapeutics Market
9.4.3.1. Treatment breakdown size & forecasts, 2022-2032
9.4.3.2. Type breakdown size & forecasts, 2022-2032
9.4.3.3. Stage breakdown size & forecasts, 2022-2032
9.4.3.4. End User breakdown size & forecasts, 2022-2032
9.5. Middle East & Africa Heart Failure Therapeutics Market
9.5.1. Saudi Arabia Heart Failure Therapeutics Market
9.5.1.1. Treatment breakdown size & forecasts, 2022-2032
9.5.1.2. Type breakdown size & forecasts, 2022-2032
9.5.1.3. Stage breakdown size & forecasts, 2022-2032
9.5.1.4. End User breakdown size & forecasts, 2022-2032
9.5.2. South Africa Heart Failure Therapeutics Market
9.5.2.1. Treatment breakdown size & forecasts, 2022-2032
9.5.2.2. Type breakdown size & forecasts, 2022-2032
9.5.2.3. Stage breakdown size & forecasts, 2022-2032
9.5.2.4. End User breakdown size & forecasts, 2022-2032
9.5.3. Rest of Middle East & Africa Heart Failure Therapeutics Market
9.5.3.1. Treatment breakdown size & forecasts, 2022-2032
9.5.3.2. Type breakdown size & forecasts, 2022-2032
9.5.3.3. Stage breakdown size & forecasts, 2022-2032
9.5.3.4. End User breakdown size & forecasts, 2022-2032
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Abbott Laboratories
10.1.2. ABIOMED, Inc.
10.1.3. Amgen Inc.
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Alembic Pharmaceuticals Limited
10.3.2. AstraZeneca PLC
10.3.3. Bayer AG
10.3.4. Beckman Coulter, Inc.
10.3.5. Berlin Heart GmbH
10.3.6. Biosensors International Group, Ltd.
10.3.7. Biotronik SE & Co. KG
10.3.8. Boston Scientific Corporation
10.3.9. Bristol-Myers Squibb Company
10.3.10. Cardiol Therapeutics Inc.
10.3.11. Cipla Limited
10.3.12. Dr. Reddy’s Laboratories Limited
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
List of Tables
TABLE 1. Global Heart Failure Therapeutics market, report scope
TABLE 2. Global Heart Failure Therapeutics market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Heart Failure Therapeutics market estimates & forecasts by Treatment 2022-2032 (USD Billion)
TABLE 4. Global Heart Failure Therapeutics market estimates & forecasts by Type 2022-2032 (USD Billion)
TABLE 5. Global Heart Failure Therapeutics market estimates & forecasts by Stage 2022-2032 (USD Billion)
TABLE 6. Global Heart Failure Therapeutics market estimates & forecasts by End User 2022-2032 (USD Billion)
TABLE 7. U.S. Heart Failure Therapeutics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. U.S. Heart Failure Therapeutics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 9. Canada Heart Failure Therapeutics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Canada Heart Failure Therapeutics market estimates & forecasts by segment 2022-2032 (USD Billion)
…..
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIG 1. Global Heart Failure Therapeutics market, research methodology
FIG 2. Global Heart Failure Therapeutics market, market estimation techniques
FIG 3. Global market size estimates & forecast methods.
FIG 4. Global Heart Failure Therapeutics market, key trends 2023
FIG 5. Global Heart Failure Therapeutics market, growth prospects 2022-2032
FIG 6. Global Heart Failure Therapeutics market, porters 5 force model
FIG 7. Global Heart Failure Therapeutics market, PESTEL analysis
FIG 8. Global Heart Failure Therapeutics market, value chain analysis
FIG 9. Global Heart Failure Therapeutics market by segment, 2022 & 2032 (USD Billion)
FIG 10. Global Heart Failure Therapeutics market by segment, 2022 & 2032 (USD Billion)
FIG 11. Global Heart Failure Therapeutics market by segment, 2022 & 2032 (USD Billion)
FIG 12. Global Heart Failure Therapeutics market by segment, 2022 & 2032 (USD Billion)
FIG 13. Global Heart Failure Therapeutics market by segment, 2022 & 2032 (USD Billion)
FIG 14. Global Heart Failure Therapeutics market, regional snapshot 2022 & 2032
FIG 15. North America Heart Failure Therapeutics market 2022 & 2032 (USD Billion)
FIG 16. Europe Heart Failure Therapeutics market 2022 & 2032 (USD Billion)
FIG 17. Asia Pacific Heart Failure Therapeutics market 2022 & 2032 (USD Billion)
FIG 18. Latin America Heart Failure Therapeutics market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa Heart Failure Therapeutics market 2022 & 2032 (USD Billion)
FIG 20. Global Heart Failure Therapeutics market, company market share analysis (2023)
…..
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.
